FDA Inspection 819296 — Amphastar Pharmaceuticals, Inc.

Amphastar Pharmaceuticals, Inc. — FEI 3002936358

The FDA completed an inspection of Amphastar Pharmaceuticals, Inc. on February 6, 2013 in Rancho Cucamonga, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 6, 2013
Fiscal Year
2013
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Rancho Cucamonga, CA (United States)

Citations

IDCFRDescription
184421 CFR 211.84(d)(2)Establish reliability of supplier's C of A
360321 CFR 211.160(b)Scientifically sound laboratory controls
437321 CFR 211.188(b)(7)Actual yield, % of theoretical yield